Small-Cell Carcinoma Treatment Cost in Germany

The cost of Small-Cell Carcinoma treatment in Germany typically ranges from $18,000 to $70,000 USD, depending on the hospital, city, and type of procedure.

This page covers small cell lung cancer, the main type of small cell carcinoma. It grows and spreads more quickly than non-small cell lung cancer. In Germany, the total depends on:

• Stage: limited or extensive.
• Chemotherapy: with carboplatin or cisplatin and etoposide.
• Radiotherapy: to the chest and sometimes the brain.
• Immunotherapy: such as atezolizumab or durvalumab.

Cancer treatment costs depend on the stage and the treatments needed. A full course of care can cost more than this range, so ask what each estimate includes.

The US National Cancer Institute (NCI) says smoking is the main risk factor, with radon and asbestos also linked. Symptoms include a cough, breathlessness, chest pain and coughing up blood.

Tests include a biopsy, bronchoscopy and CT, PET or MRI scans. The cancer is described as limited stage, when it is in one side of the chest, or extensive stage, when it has spread further.

For limited stage, the NCI describes chemotherapy with chest radiotherapy, followed by durvalumab in some people, with surgery for a few selected patients and brain radiotherapy after a complete response to lower the risk of spread there.

For extensive stage, atezolizumab or durvalumab is given with chemotherapy. Carboplatin, cisplatin and etoposide are commonly used, and the NCI notes that current treatments do not cure most patients.

Chemotherapy and immunotherapy are usually given in cycles over months, so international patients should ask how treatment could continue at home after starting in Germany. International patients are usually treated in Germany as self-paying patients: the hospital reviews the medical reports, sends a cost estimate and asks for an advance payment before admission, then settles the final bill after discharge.

Many German hospitals have cancer centres certified by the German Cancer Society (Deutsche Krebsgesellschaft), which must show every year that they meet tumour-specific requirements based on medical guidelines.